Why Tirzepatide Works Better Than GLP-1 Alone

Why Tirzepatide Works Better Than GLP-1 Alone

From The Metabolic Classroom with Dr. Ben Bikman by Insulin IQ

May 18, 2026 · 33 min · Episode 150

About this episode

Dr. Bikman explains how Tirzepatide works by activating GLP-1 and GIP receptors to aid in weight loss and improve metabolic health.

📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Tirzepatide activates both GLP-1 and GIP receptors, producing weight loss primarily through appetite suppression, slower gastric emptying, reduced cravings, and improved insulin sensitivity—not by forcing the pancreas to make more insulin. Dr. Bikman argues that its best use may be as a temporary tool to help people regain control of food choices and lower the insulin-driving habits that caused metabolic dysfunction. Summary: In this mini-lecture, Dr. Bikman explains tirzepatide, the dual-incretin drug that activates both GLP-1 and GIP receptors. While it is often described as a drug that improves glucose by increasing insulin, Dr. Bikman argues that this explanation misses the bigger metabolic picture. He begins by reviewing the incretin effect, where oral glucose produces a stronger insulin response than the same glucose given intravenously because the gut releases hormones such as GLP-1 and GIP. GLP-1 reduces appetite, slows gastric emptying, suppresses glucagon, and helps regulate glucose, while GIP has…

People in this episode

Host: Dr. Ben Bikman

Topics covered

Keywords

Mentioned in this episode

Organizations: Insulin IQ, benbikman.com, insuliniq.com, GLP-1, GIP

Products: Tirzepatide

More episodes of The Metabolic Classroom with Dr. Ben Bikman

Explore listener stats, chart rankings, contacts and more on the The Metabolic Classroom with Dr. Ben Bikman podcast page.